Monthly excess costs by source at the end of life, for eligible incident lung cancer cases diagnosed 2006–2013 who died to June 2016.
figureposted on 31.08.2020, 17:34 by David E. Goldsbury, Marianne F. Weber, Sarsha Yap, Nicole M. Rankin, Preston Ngo, Lennert Veerman, Emily Banks, Karen Canfell, Dianne L. O’Connell
In 2013 Australian dollars.
Read the peer-reviewed publication
Study Backgroundsurvival-related factorscancer typesemergency department presentationsincident lung cancersyears post-diagnosisMedicare Benefits Scheduletumour characteristicsMethods Health system costsExcess costshospital recordscancer-free controlslung cancer careConclusions Lung cancer healthcare ...Pharmaceutical Benefits Schemepopulation-based estimateshealth services costscost-effectiveness analyses2013. Costsinpatient hospitalisationshealth system costsStudy cohortAustralian 45June 2016Observed costslung cancer screening465 casestherapylung cancer